In the Wednesday afternoon session on von Willebrand disease (VWD) Jeroen C.J. Eikenboom explains the diagnosis of von Wilebrand Disease (VWD).
In the Wednesday morning lab sciences session on the genetic laboratory for bleeding disorders, Barbara A. Konkle discusses the work and experiences, to date, of the My Life, Our Future hemophilia genetic analysis project.
In the Wednesday morning session on rare and ultra-rare bleeding disorders, Jean-François Schved discusses FVII deficiency, one of the more frequent rare bleeding disorders, from the fundamentals to the bedside.
In the Vice President Medical’s plenary of the WFH 2016 World Congress, Marijke van den Berg, discusses how bleeds may be prevented by treatment in a new era for hemophilia which she qualifies as exciting times.